Misoprostol for induction of labor with a live fetus

被引:25
作者
Weeks, A. [1 ]
Alfirevic, Z. [1 ]
Faundes, A. [2 ]
Hofmeyr, G. J. [3 ]
Safar, P. [4 ]
Wing, D. [5 ]
机构
[1] Univ Liverpool, Womens Hosp, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England
[2] Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil
[3] Univ Witwatersrand, E London Hosp Complex, Effect Care Res Unit, ZA-2050 Johannesburg, South Africa
[4] Gen Publ Hosp, Dept Obstet & Gynaecol, Korneuburg, Austria
[5] Univ Calif Irvine, Dept Obstet & Gynecol, Div Maternal Fetal Med, Irvine, CA 92717 USA
关键词
misoprostol; induction of labor; prostaglandins; pregnancy;
D O I
10.1016/j.ijgo.2007.09.011
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Induction of tabor is common in clinical practice. Many different medical and mechanical methods have been used, but the current gold standard is vaginal dinoprostone. Misoprostol has been used for the induction of tabor since 1987. In early studies with large misoprostol doses (e.g. 200 mu g) there were high rates of uterine hyperstimulation. Cochrane meta-analysis, however, shows that when used in tow doses it is as effective as vaginal dinoprostone and with no excess of hyperstimulation. 25 mu g vaginal misoprostol 4-hourly, 50 mu g oral misoprostol 4-hourly or 20 mu g oral misoprostol solution 2-hourly are all safe and effective regimens. Reports of uterine rupture in women with previous cesarean sections mean that it remains contraindicated in this group. (C) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S194 / S197
页数:4
相关论文
共 21 条
[1]  
Alfirevic Z, 2003, COCHRANE DB SYST REV, V3, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858, 10.1002/14651858.CD003252]
[2]  
*AM COLL OBST GYN, 1999, ACOG PRACT B, V10
[3]  
[Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD004221.PUB2
[4]   Misoprostol induction of labor among women with a history of cesarean delivery [J].
Choy-Hee, L ;
Raynor, BD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (06) :1115-1117
[5]  
Chuck F., 1995, American Journal of Obstetrics and Gynecology, V172, P424
[6]   Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix:: a systematic review [J].
Crane, J. M. G. ;
Butler, B. ;
Young, D. C. ;
Hannah, M. E. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (12) :1366-1376
[7]   Misoprostol for intrauterine fetal death [J].
De Leon, R. Gomez Ponce ;
Wing, D. ;
Fiala, C. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 99 :S190-S193
[8]   Titrated oral misoprostol solution for induction of labour: a multi-centre, randomised trial [J].
Hofmeyr, GJ ;
Alfirevic, Z ;
Matonhodze, B ;
Brocklehurst, P ;
Campbell, E ;
Nikodem, VC .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (09) :952-959
[9]  
HOFMEYR GJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000941
[10]  
Kelly AJ, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003101, 10.1002/14651858.CD003101]